Cargando…
The Role of Biomarkers in Cardio-Oncology
In the field of cardio-oncology, it is well recognised that despite the benefits of chemotherapy in treating and possibly curing cancer, it can cause catastrophic damage to bystander tissues resulting in a range of potentially of life-threatening cardiovascular toxicities, and leading to a number of...
Autores principales: | Ananthan, Kajaluxy, Lyon, Alexander R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360533/ https://www.ncbi.nlm.nih.gov/pubmed/32642841 http://dx.doi.org/10.1007/s12265-020-10042-3 |
Ejemplares similares
-
Cardio-oncology: Concepts and practice
por: Cubbon, Richard M., et al.
Publicado: (2016) -
Cardio-Oncology: Mechanisms, Drug Combinations, and Reverse Cardio-Oncology
por: Liang, Zehua, et al.
Publicado: (2022) -
Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention
por: Albini, Adriana, et al.
Publicado: (2010) -
Cardiac biomarkers in the field of cardio-oncology
por: Cardinale, Daniela, et al.
Publicado: (2022) -
The year in cardiovascular medicine 2022: the top 10 papers in cardio-oncology
por: Herrmann, Joerg, et al.
Publicado: (2023)